Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 21 (NPM1P21) is a processed pseudogene related to the NPM1 gene, which encodes nucleophosmin, a multifunctional nucleolar phosphoprotein involved in ribosome biogenesis, cell proliferation, and genomic stability[4][1]. However, as a pseudogene, NPM1P21 lacks the capacity to encode a functional protein and thus does not play an active biological role; it is not established as a therapeutic target, nor does it serve as a biomarker or interact with drugs. The NPM1 gene and its protein product are clinically relevant in hematologic cancers such as acute myeloid leukemia (AML), but the pseudogene NPM1P21 is distinct and unrelated to these disease mechanisms or drug targets[5][2]. Pseudogenes are often denoted by supplementary numbers (e.g., “pseudogene 21”) and are non-functional gene copies; they do not produce proteins or act as receptors, enzymes, or signaling molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 21 (NPM1P21).